An epitaxial orientation of Fe/Cr superlattices -Fe/Cr(211) on MgO(110)is grown by magnetron sputtering.Its structural and magnetic characterizations are presented and compared to those for Fe/Cr(100) superlattices grown simultaneously onto MgO(100) substrates. The epitaxial orientation of the Fe/Cr (211) superlattices is Fe/Cr[011]~iMgO[001] and Fe/Cr[111]iiMgO[110], while that for Fe/Cr(100) is Fe/Cr[001]~~MgO[011]. A uniaxial, in-plane surface anisotropy for the Fe/Cr(211) superlattices along the Fe[011]of 0.06 erg/cm2 is obtained from analysis of the magnetization hysteresis loops.Four oscillations in the antiferromagnetic interlayer coupling and giant magnetoresistance (CiMR) are 0 observed with a period of 18 A for both orientations. The strength, oscillation period, and phase of the magnetic coupling are identical for the two orientations. The GMR values increase by a factor of -4 to 5 on cooling from room temperature to 4.2 K. At 4.2 K the maximum GMR value of the [Fe(14 A)/Cr(8 A)],0 superlattice is 70% for the (211) orientation and 150% for the (100) orientation.
Structural, magnetic, and superconducting properties of ferromagnetic/superconducting multilayers of Fe 4 N/NbN are explored for a variety of thickness combinations. The superconducting properties show that 11 Å ferromagnetic layers are sufficient to decouple the superconducting layers and to yield anisotropic behavior. The upper critical field data are well described by theory for ferromagnetic/superconducting multilayers. This analysis yields an interfacial parameter which characterizes the electron scattering at the ferromagnetic/ superconducting boundary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.